跳至主要内容
临床试验/NCT02925130
NCT02925130已完成不适用

Beta2-mimetic and Central Nervous System: Effects of Salbutamol on Cortical Excitability and Cerebral Activation

University Hospital, Grenoble1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2016年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
15
试验地点
1
主要终点
Maximal voluntary activation

研究概览

简要总结

Beta2-mimetics such as Salbutamol have been shown to have ergogenic effects. Acute and chronic inhaled or oral doses of Salbutamol have been shown to increase whole body exercise and muscle performances. The underlying mechanisms are however unclear. Some data suggest that Salbutamol may have some effects on the central nervous system which may explain the improved exercise and neuromuscular performances. The present study aims to assess the effects of acite inhaled or oral Salbutamol intake on the neuromuscular system by using neurostimulation techniques and magnetic resonance imaging.

详细描述

The effects of Salbutamol intake will be assessed by using transcranial magnetic stimulation on one hand and magnetic resonance imaging on the other hand. Maximal voluntary activation and cerebral activation will be measured during motor tasks performed until exhaustion after acute inhaled slabutamol intake, acture oral salbutamol intake or oral placebo intake.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy subjects without respiratory and cordiovascular diseases
  • Age between 18 and 35
  • Trained subjects (>6 hours of physical activity per week)
  • Non- or ex-smoker (smoking cessation since at least 1 year)

排除标准

  • Respiratory, cardiovascular and metabolic diseases
  • Neuromuscular diseases
  • thyrotoxicosis, or diabetes treated with insulin
  • alcoholism
  • MRI contraindication
  • TMS contraindication

研究组 & 干预措施

Inhaled Salbutamol

Experimental

Acute inhalation of 800 microgram Salbutamol

干预措施: Salbutamol (Drug)

Oral Salbutamol

Experimental

Acute oral intake of 4 mg Salbutamol

干预措施: Salbutamol (Drug)

Placebo

Placebo Comparator

Acute oral intake of a placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Maximal voluntary activation

时间窗: Measured immediatly after treatment intake (within 1 h)

Measurement performed by using transcranial magnetic stimulation, superimposed on submaximal and maximal quadricep contractions

次要结局

  • Exercise endurance(Measured immediatly after treatment intake (within 1 h))
  • Cortical activation(Measured immediatly after treatment intake (within 1 h))

研究者

发起方
University Hospital, Grenoble
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验